Generics and Biosimilars Initiative (GaBI), founded by Professor Huub Schellekens, Professor Arnold G Vulto, both from The Netherlands; and Ms Lasia Tang from Belgium; aims to foster the worldwide efficient use of high-quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable healthcare.

The objective of GaBI is to raise the scientific status of generic and biosimilar medicines, via well-documented and up-to-date information about generic and biosimilar medicines both in print and electronically (www.gabionline.net) in an open access format, providing high-quality, scientifically sound and reliable information to healthcare professionals including physicians, pharmacists and nurses, consumers, drug developers, third party payers, legislators and assessors; who are in need of a reliable, critical and independent source of information on all aspects of generic and biosimilar medicines.

GaBI’s mission - building trust in cost-effective treatments.

Ltang@gabionline.net - www.gabionline.net